PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression Jun 15, 2021
Traction for Psychedelics: First Psychedelics ETF Comes to the US as Bills Move Forward in California, Texas, and New… Jun 9, 2021
What Is A Compassionate Access Trial? Numinus CSO & Co-Founder Stacey Wallin Has The Details Jun 7, 2021
National Institutes of Health Director Praises Psychedelics and Medical Cannabis Research May 31, 2021
